NCT05924230 is a NA clinical trial of RL 10ml/kg in Post Induction Hypotension, sponsored by Tata Main Hospital.

Who is sponsoring NCT05924230?

NCT05924230 is sponsored by Tata Main Hospital.

What drugs are being tested in NCT05924230?

Interventions in NCT05924230: RL 10ml/kg, RL 15ml/kg.

What condition does NCT05924230 study?

NCT05924230 studies Post Induction Hypotension.

Is NCT05924230 still recruiting?

NCT05924230 is currently status unknown. Last updated 29 June 2023.

Last reviewed 2023-06-29 · How we verify

NCT05924230

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dose Responsive Study of Ringer's Lactate Solution in Prevention of Post-induction Hypotension

Status unknown NA Last updated 29 June 2023

What this trial tests

NA trial testing RL 10ml/kg in Post Induction Hypotension in 100 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
30 June 2024

31 August 2024

Quick facts

Lead sponsor	Tata Main Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	100
Start date	1 April 2023
Primary completion	30 June 2024
Estimated completion	31 August 2024
Sites	1 location across India

Drugs / interventions tested

RL 10ml/kg
RL 15ml/kg

Conditions studied

Post Induction Hypotension — all drugs for Post Induction Hypotension →

Sponsor

Tata Main Hospital

Who can join

Adults 18 to 65, any sex, with Post Induction Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the dose responsiveness of ringer lactate solution in prevention of post-induction hypotension predicted by Ultrasound guided Inferior Vena Cava diameter in patients receiving General anesthesia. OBJECTIVES Primary - To find the optimum preloading dosage of Ringer Lactate to prevent post induction hypotension. Secondary - To find the predictive incidence of Post-induction hypotension according to age, gender, type of surgery and comorbidities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tata Main Hospital trials

Trials by the same sponsor.

NCT07328893 — Effect of Single Dose Intravenous Magnesium Sulfate on Postoperative Analgesic Consumption in Patients Undergoing Laparo · Phase 4 · recruiting
NCT06602505 — Comparative Analysis of Incidence of Newly Developed Postoperative Low Back Pain with Field Block Versus Without Field-b · NA · completed
NCT06598566 — A Comparative Evaluation of Nottingham Hip Fracture Score (NHFS) and Acute Physiology and Chronic Health Evaluation (APA · completed
NCT04605952 — Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive · completed
NCT03793751 — Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05924230 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tata Main Hospital
Last refreshed: 29 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924230.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing